Medicare Enrolled
Dr. Alexander Weingarten, MD
Interventional Pain Medicine Physician · Syosset, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Weingarten from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weingarten?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Weingarten
Dr. Alexander Weingarten is an interventional pain medicine physician in Syosset, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Weingarten performed 7,647 Medicare services across 2,789 unique beneficiaries.
Between the years covered by Open Payments, Dr. Weingarten received a total of $63,802 from 83 pharmaceutical and/or device companies across 2038 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Weingarten is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 15% volume in NY
$63,802 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,647
Medicare services
Top 15% in NY for interventional pain medicine physician
2,789
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~382 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,350 | $77 | $108 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
1,861 | $12 | $25 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
707 | $61 | $100 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
667 | $153 | $900 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
383 | $242 | $1,300 |
| Injection, methylprednisolone acetate, 40 mg | 253 | $6 | $104 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
221 | $9 | $113 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
221 | $0 | $101 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
179 | $234 | $500 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
138 | $51 | $70 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
94 | $195 | $1,150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
90 | $148 | $198 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
80 | $55 | $75 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
69 | $107 | $138 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
59 | $47 | $65 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
50 | $228 | $306 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
41 | $248 | $500 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
33 | $5 | $101 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
25 | $90 | $150 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
25 | $406 | $539 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
25 | $232 | $296 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
19 | $51 | $80 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $52 | $68 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
14 | $58 | $80 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
14 | $73 | $93 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $107 | $151 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$63,802
Total received (2018-2024)
Avg $9,115/year across 7 years
Top 11% in NY for interventional pain medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
83
Companies
2,038
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,260 (39.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24,539 (38.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$14,003 (21.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,729
2023
$3,776
2022
$3,155
2021
$7,761
2020
$3,890
2019
$15,396
2018
$26,094
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Collegium Pharmaceutical, Inc.
$835
SCILEX PHARMACEUTICALS INC.
$497
ABBVIE INC.
$466
Valinor Pharma, LLC
$337
PFIZER INC.
$280
Forte Bio-Pharma LLC
$205
Nevro Corp.
$197
Takeda Pharmaceuticals U.S.A., Inc.
$187
TerSera Therapeutics LLC
$161
Azurity Pharmaceuticals, Inc.
$125
PROTEGA PHARMACEUTIALS INC
$89
VERTEX PHARMACEUTICALS INCORPORATED
$71
Medtronic, Inc.
$70
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$49
Abbott Laboratories
$40
IDORSIA PHARMACEUTICALS US INC
$36
Orexo US, Inc.
$35
Boston Scientific Corporation
$32
DePuy Synthes Sales Inc.
$18
Top 3 companies account for 48.2% of 2024 payments
All-time payments by company (2018-2024) ›
West Therapeutics Development, LLC
$8,702
US WorldMeds, LLC
$7,238
Pernix Therapeutics Holdings, Inc.
$6,001
BioDelivery Sciences International, Inc.
$5,986
Collegium Pharmaceutical, Inc.
$4,847
INSYS Therapeutics Inc
$4,512
Regeneron Pharmaceuticals, Inc.
$1,860
Takeda Pharmaceuticals U.S.A., Inc.
$1,844
AbbVie Inc.
$1,509
Biohaven Pharmaceuticals, Inc.
$1,425
Daiichi Sankyo Inc.
$1,387
SCILEX PHARMACEUTICALS INC.
$1,116
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$1,110
RedHill Biopharma Inc.
$962
TerSera Therapeutics LLC
$945
ABBVIE INC.
$851
Scilex Pharmaceuticals Inc.
$818
Horizon Therapeutics plc
$731
Kowa Pharmaceuticals America, Inc.
$722
Nevro Corp.
$709
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$687
PFIZER INC.
$655
ARBOR PHARMACEUTICALS, INC.
$586
Forte Bio-Pharma LLC
$511
Eisai Inc.
$489
Valinor Pharma, LLC
$484
Allergan, Inc.
$437
Medtronic USA, Inc.
$400
Virtus Pharmaceuticals LLC
$389
AKRIMAX PHARMACEUTICALS, LLC
$385
Biohaven Pharmaceutical Holding Company Ltd.
$373
Sentynl Therapeutics, Inc.
$297
Almatica Pharma LLC
$285
Assertio Therapeutics, Inc.
$268
Amgen Inc.
$235
Merck Sharp & Dohme Corporation
$230
AstraZeneca Pharmaceuticals LP
$209
Egalet US Inc
$183
ASSERTIO THERAPEUTICS, Inc.
$183
Merck Sharp & Dohme LLC
$180
FORTE BIO-PHARMA LLC
$176
Azurity Pharmaceuticals, Inc.
$175
PROTEGA PHARMACEUTIALS INC
$160
Arbor Pharmaceuticals, Inc.
$143
Zyla Life Sciences
$142
USWM, LLC
$135
Kaleo, Inc.
$125
Abbott Laboratories
$120
Supernus Pharmaceuticals, Inc.
$108
Orexo US, Inc.
$106
Indivior Inc.
$104
Allergan Inc.
$99
IBSA Pharma Inc.
$97
Avanos Medical
$92
Medtronic, Inc.
$91
Bausch Health US, LLC
$78
Teva Pharmaceuticals USA, Inc.
$76
GRT US Holding, Inc.
$76
EISAI INC.
$73
Jazz Pharmaceuticals Inc.
$73
VERTEX PHARMACEUTICALS INCORPORATED
$71
Vertical Pharmaceuticals, LLC
$68
Boston Scientific Corporation
$65
Purdue Pharma L.P.
$54
IDORSIA PHARMACEUTICALS US INC
$53
BOSTON SCIENTIFIC CORPORATION
$51
Pacira Pharmaceuticals Incorporated
$50
Lilly USA, LLC
$47
Currax Pharmaceuticals LLC
$38
DePuy Synthes Sales Inc.
$37
Hikma Pharmaceuticals USA
$33
IMPEL PHARMACEUTICALS INC.
$30
Zyla Life Sciences, Inc.
$29
Sun Pharmaceutical Industries Inc.
$28
ERMI LLC
$27
Promius Pharma LLC
$25
Bioventus LLC
$22
SI-BONE, Inc.
$16
Shionogi Inc
$15
SI-BONE, INC.
$14
Neuronetics, Inc.
$14
Baudax Bio Inc.
$13
SUN PHARMACEUTICAL INDUSTRIES INC.
$13
Top 3 companies account for 34.4% of all-time payments
Associated products mentioned in payments ›
AJOVY · AMITIZA · ANJESO · ARYMO ER · Aemcolo · Aimovig · Amitiza · BELBUCA · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · COLOGUARD · COMIRNATY · CONTRAVE · Cambia · DUEXIS · Dayvigo · ELYXYB - CELECOXIB · EMGALITY · EXPAREL · EZALLOR SPRINKLE · Edarbi · Entyvio · Evzio · Exparel · FLECTOR · Flector · GELSYN 3 · GENERAL PAIN MANAGEMENT · GENERATOR · GRALISE · Gralise · HORIZANT · Horizant · IFUSE IMPLANT · INTELLIS · INTELLIS ADAPTIVESTIM · KAPSPARGO · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · Kloxxado · LACTULOSE · LEVORPHANOL TARTRATE · LIVALO · LORZONE · LUCEMYRA · LYRICA · Lazanda · Levorphanol · Levorphanol Tartrate · Licart · Lucemyra · Lucemyra/Lofexidine · MIGRANAL · MOVANTIK · Morphabond ER · Movantik · NALOCET · NAPRELAN · NEUROSTAR TMS THERAPY · NURTEC ODT · Nucynta · NucyntaER · ORTHOVISC · OXAYDO · Omnia · PAXLOVID · PENNSAID · PRIALT · PROCLAIM · PROLATE · Prialt · Primlev · Proclaim Family of SCS IPGs · QULIPTA · QUVIVIQ · Qutenza · RAYOS · RELISTOR · RELISTOR ORAL · REYVOW · ROXYBOND · SEGLENTIS · SPECTRA WAVEWRITER · SPRIX · SUBLOCADE · SUBSYS · SYMJEPI · SYMPROIC · Seglentis · Senza · Senza Spinal Cord Stimulation System · Symproic · TREXIMET · TRINTELLIX · TROKENDI XR · Talicia · Tirosint · Trintellix · Trudhesa · UBRELVY · VIBERZI · Vyvanse · XTAMPZA · XTAMPZAER · Xtampza ER · ZAVZPRET · ZIPSOR · ZOHYDRO ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zipsor · Zubsolv · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (40%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional pain medicine physicians within 10 mi
45
Per 100K population
3.2
County median income
$143,408
Nearest hospital
PLAINVIEW HOSPITAL
3.5 mi
3.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Weingarten is a clinical cardiology specialist, with above-average Medicare volume (top 15% in NY), with mixed engagement industry engagement in the top 11% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Weingarten experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Weingarten performed 2,350 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Weingarten receive payments from pharmaceutical companies?
Yes. Dr. Weingarten received a total of $63,802 from 83 companies across 2,038 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weingarten's costs compare to other interventional pain medicine physicians in Syosset?
Dr. Weingarten's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weingarten) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Syosset
Browse interventional pain medicine physicians in Syosset ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in NY
Interventional pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in NY
Which NY interventional pain medicine physicians receive the most from drug and device companies.
By company
West Therapeutics Development, LLC Payments to Doctors
See all physicians who received payments from West Therapeutics Development, LLC.
By company
US WorldMeds, LLC Payments to Doctors
See all physicians who received payments from US WorldMeds, LLC.
By company
Pernix Therapeutics Holdings, Inc. Payments to Doctors
See all physicians who received payments from Pernix Therapeutics Holdings, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology